Getting your consults…

Find the Best Treatments for Your Condition

Real experiences. Better treatment choices

Tenecteplase

Other names: TNKase

Categories: Prescription Medication

Default Image

Description:

Tenecteplase (brand name TNKase) is now FDA-approved for the treatment of acute ischemic stroke in adults as of March 2025. It works by dissolving clots through plasminogen activation, similar to alteplase, but offers the advantage of a single IV bolus dose rather than a prolonged infusion. Clinical studies have shown it to be as effective as alteplase, with comparable safety and functional outcomes. Because of its ease of administration and rapid delivery, it is now considered a strong alternative

Treatment For:

AI generated Summary: Based on the provided information, there are no reviews or ratings available for the effectiveness of Tenecteplase in treating Ischemic Cerebrovascular Accident. The author has not provided any review or rating for this treatment. Therefore, it is not possible to determine the effectiveness of Tenecteplase for Ischemic Cerebrovascular Accident based on the given data.

Reviews

Average rating: 5/5
Physician ( 1 )
  • 5
    1
  • 4
    0
  • 3
    0
  • 2
    0
  • 1
    0
Average rating: 5.00/5
Total Reviews: 1
  • 5
    1
  • 4
    0
  • 3
    0
  • 2
    0
  • 1
    0

Dr. Curbside

  • September 18, 2025

5.0

Write a Review
Disclaimer

The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.

➕ Add Condition